Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study

Makoto Takaki, Kazuya Ichikado, Kodai Kawamura
European Respiratory Journal 2016 48: PA3570; DOI: 10.1183/13993003.congress-2016.PA3570
Makoto Takaki
1Division of Respiratory Medicine, Social Welfare Organization Imperial Gift Foundation, Inc, Saiseikai Kumamoto Hospital, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuya Ichikado
1Division of Respiratory Medicine, Social Welfare Organization Imperial Gift Foundation, Inc, Saiseikai Kumamoto Hospital, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kodai Kawamura
1Division of Respiratory Medicine, Social Welfare Organization Imperial Gift Foundation, Inc, Saiseikai Kumamoto Hospital, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: The efficacy of corticosteroid use in ARDS remains controversial. Generally, short-term high-dose corticosteroid therapy is considered to be ineffective in ARDS. On the other hand, low-dose, long-term use of corticosteroids has been reported to be effective since they provide continued inhibition of the systemic inflammatory response syndrome (SIRS) that accompanies ARDS.

Methods: We conducted a prospective observational study involving 190 cases treated at a teaching hospital (90% had infections). ARDS was diagnosed according to the Berlin definition. Cases were divided into a high-dose (n=21) or low-dose corticosteroid group (n=169) to compare the effectiveness of a down-titration regimen. The primary medical team chose which treatment a patient would receive. We were careful to conduct a differential diagnosis of interstitial pneumonia since corticosteroid treatment has been proven effective in that patient population. Primary outcome was the 60-day mortality rate.

Results: Those started on a high-dose regimen had a significantly higher 60-day mortality rate (66.7% vs 42.0%, P = 0.028) with significantly fewer ventilation-free days (VFD) (4.57 ± 8.52 vs 9.34 ± 9.37, P = 0.024). Propensity scores were used to match patient backgrounds in a variable analysis that also showed the high-dose regimen was a factor in worsening 60-day mortality rate (OR, 3.403; 95% CI, 1.025 -11.299; P = 0.045).

Conclusions: Initiating treatment with high-dose corticosteroids and a tapering regimen is likely to worsen the prognosis of patients with ARDS due to infections that meet the Berlin definition.

  • ARDS (Acute Respiratory Distress Syndrome)
  • Interstitial lung disease
  • Critically ill patients
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study
Makoto Takaki, Kazuya Ichikado, Kodai Kawamura
European Respiratory Journal Sep 2016, 48 (suppl 60) PA3570; DOI: 10.1183/13993003.congress-2016.PA3570

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: A retrospective propensity matched cohort study
Makoto Takaki, Kazuya Ichikado, Kodai Kawamura
European Respiratory Journal Sep 2016, 48 (suppl 60) PA3570; DOI: 10.1183/13993003.congress-2016.PA3570
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Non-invasive ventilation in the emergency department from 2004-2015
  • Acute respiratory failure in progressive neurological diseases: What is important for intensive care unit and long-term survival?
Show more 2.1 Acute Critical Care

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society